MXCT Latest Quarter’s Earnings
Announce Date8/12/2026
EPS Actual (USD)-0.08
Revenue Actual (USD)7.27M
MaxCyte Inc Earnings Dates & Reports
This page offers detailed MaxCyte Inc earnings data including the latest MaxCyte Inc earnings report, the upcoming MaxCyte Inc earnings date, historical data and MaxCyte Inc earnings call news.
MXCT Upcoming Quarter's Earnings
Announce Date--
EPS Forecast (USD)--
Revenue Forecast (USD)--
MXCT FY2025 Earnings
EPS (YoY)-0.42-7.10%
Revenue (YoY)33.03M-14.50%
MaxCyte Inc (MXCT) Earnings History
| Release Date | Period End | EPS/Forecast | Revenue/Forecast | EPS Surprise % | Revenue Surprise % |
|---|---|---|---|---|---|
| 8/12/2026 | 06/2026 | -0.08/-0.09 | 7.27M/6.48M | 7.70% | 12.29% |
| 5/12/2026 | 03/2026 | -0.04/-0.08 | 9.65M/7.30M | 44.45% | 32.24% |
| 3/24/2026 | 12/2025 | -0.09/-0.08 | 7.30M/9.41M | -12.37% | -22.39% |
| 11/12/2025 | 09/2025 | -0.12/-0.11 | 6.83M/8.37M | -5.87% | -18.41% |
| 8/6/2025 | 06/2025 | -0.12/-0.10 | 8.51M/9.53M | -12.39% | -10.72% |
| 5/7/2025 | 03/2025 | -0.10/-0.10 | 10.39M/9.68M | 7.76% | 7.39% |
| 3/11/2025 | 12/2024 | -0.10/-0.12 | 8.69M/7.93M | 17.70% | 9.66% |
| 11/6/2024 | 09/2024 | -0.11/-0.12 | 8.16M/7.37M | 10.85% | 10.71% |
MaxCyte Inc Latest Earnings Call Transcripts
MaxCyte (MXCT) Q2 2026 Earnings Call: Guidance Reaffirmed as Genentech Partnership Expands
MaxCyte Q2 2026 revenue fell 15% to $7.3 million, while costs declined and 2026 guidance was maintained. Genentech and DTx support second-half growth.